Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02334228
Other study ID # Concord InSHAPE
Secondary ID
Status Completed
Phase N/A
First received January 6, 2015
Last updated January 7, 2015
Start date September 2006
Est. completion date August 2009

Study information

Verified date January 2015
Source Dartmouth-Hitchcock Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Few studies targeting obesity in serious mental illness have reported clinically significant risk reduction, and non have been replicated in community settings or demonstrated sustained outcomes after intervention withdrawal. The researchers sought to replicate positive health outcomes demonstrated in a previous randomized effectiveness study of the In SHAPE program across urban community mental health organizations serving an ethnically diverse population.


Description:

In this randomized, controlled study, 133 adults age 21 and older with serious mental illness (SMI) and poor physical fitness (BMI>25, or <10 minutes of exercise 2x over the past month) were randomized to either: a) In SHAPE Lifestyles (ISL) intervention or b) Health Club Membership and Education (HCME): consisting of a YMCA membership, educational materials on exercise and healthy diet, and an on-site introduction to the health club. The following three specific aims were addressed: 1) To compare ISL and HCME with respect to: a) participation in regular exercise and dietary change; (b) participation in preventive health care; and (c) improved fitness and health; (2) to compare ISL and HCME with respect to: (a) indicators of mental health and (b) personal self-efficacy; and (3) to explore differences in ISL and HCME with respect to (a) selected physical, metabolic, dietary, and community functioning secondary outcomes; and (b) the relationship of demographic variables and readiness to change to outcomes. ISL participants received a 6-month intensive program of one-to-one health mentoring, followed by a 3-month period of transitioning to self-directed individual and group programming, with assessments conducted at baseline, 3, 6, 9, and 12 months. If found to be effective, ISL will provide a practical approach to improving health, independent functioning, and longevity in disabled persons with SMI.


Recruitment information / eligibility

Status Completed
Enrollment 133
Est. completion date August 2009
Est. primary completion date August 2009
Accepts healthy volunteers No
Gender Both
Age group 21 Years and older
Eligibility Inclusion Criteria:

- Age 21 or older

- Serious mental illness defined by an axis I diagnosis of major depression, bipolar disorder, schizoaffective disorder, or schizophrenia

- Persistent impairment in multiple areas of functioning (e.g., work, school, self-care)

- Body mass index (BMI) greater than 25

- Able and willing to provide informed consent

- On stable pharmacological treatment (same psychiatric medications over prior 2 months)

Exclusion Criteria:

- Residing in a nursing home of other institution

- Diagnosis of dementia or significant cognitive impairment (MMSE<24)

- Unable to walk one city block

- Pregnant or planning to become pregnant within the next 18 months

- Unable to speak English

- Terminal illness with life expectancy <1 year

- Current diagnosis of an active substance dependence disorder

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention


Intervention

Behavioral:
In SHAPE Lifestyles
In SHAPE Lifestyles is a health promotion intervention consisting of a fitness club membership and a health promotion coach with basic certification as a fitness trainer, instruction on principles of healthy eating and nutrition, and training in tailoring individual wellness plans to the needs of persons with serious mental illness.
Health Club Membership and Education
Fitness club membership with education in using the exercise equipment.

Locations

Country Name City State
United States Riverbend Community Mental Health Concord New Hampshire

Sponsors (1)

Lead Sponsor Collaborator
Dartmouth-Hitchcock Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Exercise Capacity Change in fitness as measured by the 6-minute walk test. Baseline, 3-, 6-, 9-, and 12-months No
Secondary Body Mass Index Baseline, 3-, 6-, 9-, and 12-months No
Secondary Change in Weight Change in weight over time was measured at baseline, 3-, 6-, 9-, and 12-months. Measures were weight (lbs). Baseline, 3-, 6-, 9-, and 12-months No
Secondary Change in Triglycerides and Cholesterol Change in triglycerides and cholesterol measured with the CardioChek PA Analyzer: Fasting blood glucose and lipids. Baseline, 3-, 6-, 9-, and 12-months No
Secondary Change in Health Status Change in health status was measured by the SF-12: Medical Outcomes Study Short Form -12 Baseline, 3-, 6-, 9-, and 12-months No
Secondary Change in Community Functioning Change in community functioning was measured by the ILSS: Independent Living Skills Scale Baseline, 9-, and 12-months No
Secondary Change in Physical Measurements (Fitness) Change is physical measurements was determined by measuring waist circumference and resting pulse Baseline, 3-, 6-, 9-, and 12-months No
Secondary Change in Psychological State Change in psychological state was measured using the CESD: Cntr Epid Studies Dep; SANS: Scale Assess Neg Sx; R-SES: Revised Self-efficacy Scale Baseline, 3-, 6-, 9-, and 12-months No
Secondary Change in Participation in Exercise Change in participation in exercise was determined by measuring weekly exercise at 3-, 6-, 9-, and 12-months using a physical activity log; weekly health club attendance at 3-, 6-, 9-, and 12-months based on frequency of YMCA visits; total physical activity at baseline, 3-, 6-, 9-, and 12-months based on the YPAS: Yale Physical Activity Scale. Baseline, 3-, 6-, 9-, and 12-months No
Secondary Change in Diet Behaviors Change in diet behaviors was measured based on the WLB-SOC: Weight Loss Behavior State of Change Scale. Baseline, 3-, 6-, 9-, and 12-months No
Secondary Change in Preventative Health Care Change in preventative health care was based on the PHC: Preventative Healthcare Checklist Baseline and 12-months No
See also
  Status Clinical Trial Phase
Recruiting NCT05039489 - A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia N/A
Completed NCT05111548 - Brain Stimulation and Cognitive Training - Efficacy N/A
Completed NCT05321602 - Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder Phase 1
Completed NCT04503954 - Efficacy of Chronic Disease Self-management Program in People With Schizophrenia N/A
Completed NCT02831231 - Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium Phase 1
Completed NCT05517460 - The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center N/A
Completed NCT03652974 - Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy Phase 4
Recruiting NCT04012684 - rTMS on Mismatch Negativity of Schizophrenia N/A
Recruiting NCT04481217 - Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia N/A
Completed NCT00212784 - Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935) Phase 3
Completed NCT04092686 - A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia Phase 3
Completed NCT01914393 - Pediatric Open-Label Extension Study Phase 3
Recruiting NCT03790345 - Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics Phase 2/Phase 3
Recruiting NCT05956327 - Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training N/A
Terminated NCT03209778 - Involuntary Memories Investigation in Schizophrenia N/A
Terminated NCT03261817 - A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders N/A
Completed NCT02905604 - Magnetic Stimulation of the Brain in Schizophrenia or Depression N/A
Recruiting NCT05542212 - Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia N/A
Completed NCT04411979 - Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia N/A
Terminated NCT03220438 - TMS Enhancement of Visual Plasticity in Schizophrenia N/A